AstraZeneca to Build $1.5B ADCs Manufacturing Facility in Singapore
In a strategic move to bolster its global supply of antibody-drug conjugates (ADCs), AstraZeneca has announced the development of a
Read moreIn a strategic move to bolster its global supply of antibody-drug conjugates (ADCs), AstraZeneca has announced the development of a
Read moreimusyn offers an unmatched portfolio of top-tier recombinant HLA class I and class II proteins, produced as truncated, soluble antigens
Read moreimusyn’s imuPep Class I Peptide Binding Analysis is designed to determine the stability of peptide/HLA class I complexes, allowing researchers
Read moreThe cutting-edge AcuiSee device for visual acuity testing of laboratory animals stands out as a breakthrough in the realm of
Read moreThe unique OptoDrum device for automated in vivo assessment of visual performance in mice and rats offers unmatched capabilities for
Read moreTakeda has secured an exclusive global option and license agreement for AC Immune’s promising active immunotherapy targeting amyloid beta for
Read moreThe Behring Campus Eystrup is a cutting-edge research facility specialising in animal immunology, antibody development, and preclinical research. Located at
Read moreParkinson’s disease (PD) is a progressive neurodegenerative condition impacting millions globally. While a blend of genetic, environmental, and ageing factors
Read moreStriatech is excited to exhibit at the upcoming annual ARVO Meeting in Seattle, Wash, which will be held between the
Read morePfizer announced on Friday that the U.S. FDA has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate
Read more